EMEA: Guideline on the Clinical Investigation of Medicinal Products for the Treatment of Ankylosing Spondylitis
22.05.2009
This Guideline is intended to provide guidance for the clinical evaluation of new medicinal products for the treatment of ankylosing spondylitis (AS), a chronic inflammatory disease that affects primarily the sacroiliac joints and the axial skeleton.
The source of the news: http://www.emea.europa.eu/pdfs/human/ewp/489103enfin.pdf
SciencePharma
